European Union

EPO Patent Grant for Glucoamylase Variants and Polynucleotides

The European Patent Office has granted patent EP3610027B1 for glucoamylase variants and polynucleotides encoding them. The patent is effective March 18, 2026, and applies to designated states within the European Union.

EPO Patent Granted: Method for Treating Stroke Effects

The European Patent Office (EPO) has granted patent EP3513797B1 for a method treating the effects of stroke. The patent was granted on March 18, 2026, and lists Simon Andrea Koblar, Stan Gronthos, and Agnieszka Arthur as inventors. This grant is part of the EPO's regular patent bulletin.

EPO Patent Granted for Urea Cycle Disorder Treatment

The European Patent Office (EPO) has granted patent EP3714048B1 for polynucleotides that treat urea cycle disorders. The patent, listing inventors from France and the US, was granted on March 18, 2026, and covers various European states.

EPO Patent Publication: Compositions for Treating Cancers

The European Patent Office has published patent application EP2026030629A1 concerning compositions and methods for treating cancers. The publication date is March 18, 2026, and it includes various International Patent Classification codes related to pharmaceutical compositions and medical treatments.

EPO Patent Application: Modified Bacteria for Reproductive Health

The European Patent Office has published patent application EP2026030562A1 concerning modified bacteria for reproductive health. The publication date is March 18, 2026, and it includes IPC classifications related to biotechnology and pharmaceuticals. The designation of the inventor has not yet been filed.

EPO Patent EP2026030634A2: Sustained Transgene Expression Fusion Polypeptides

The European Patent Office has published patent application EP2026030634A2 concerning sustained transgene expression fusion polypeptides. The application details specific fusion polypeptides and their uses, with inventors not yet designated.

EPO Patent Publication: Bioengineered Bacteria for Biofilm Curation

The European Patent Office has published a new patent application, EP2026030202A1, concerning the use of bioengineered bacteria for curating biofilms. The publication date is March 18, 2026, and it covers various International Patent Classifications related to medical treatments and biotechnology.

Degradable Branched Polymers for Biomolecule Delivery Patent

The European Patent Office has published a patent application (EP2026030568A1) for degradable branched polymers intended for biomolecule delivery. The publication date is March 18, 2026, and the inventors have not yet filed their designation.

EPO Patent Application EP2026030647A1 for Molecules Controlling Allergic Diseases

The European Patent Office has published patent application EP2026030647A1 concerning molecules for controlling allergic diseases. The application was published on March 18, 2026, and lists various IPC classifications related to biotechnology and pharmaceuticals. The designation of inventors has not yet been filed.

Therapeutic Agent Delivery Methods via Ultrasound Patent Application

The European Patent Office has published patent application EP2026030486A1 concerning methods and compositions for delivering therapeutic agents via ultrasound. The publication date is March 18, 2026, and it covers various IPC classifications related to biotechnology and drug delivery.